Judge finds Humana lacks standing to sue Biogen over MS drug payments

A federal judge in Massachusetts recently dismissed a case brought by Humana Inc. accusing drug manufacturer Biogen Inc. of making unlawful donations to different charities to help fund patient copays of its multiple sclerosis drugs as a means of increasing its number of prescriptions and sales, BenefitsPro reports. In September 2021, Humana filed a complaint that claimed Biogen developed a scheme to lure Medicare and its insurers to overpay for Tysabri, Avonex, and Tecfidera, which cost about $50,000 to $80,000 per year.